|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM333356047 |
| 003 |
DE-627 |
| 005 |
20231225221510.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2021 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2021.108887
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1111.xml
|
| 035 |
|
|
|a (DE-627)NLM333356047
|
| 035 |
|
|
|a (NLM)34798240
|
| 035 |
|
|
|a (PII)S1521-6616(21)00224-2
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Sumiyoshi, Remi
|e verfasserin
|4 aut
|
| 245 |
1 |
2 |
|a A case of tocilizumab-refractory idiopathic multicentric Castleman's disease successfully treated with sirolimus
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 03.01.2022
|
| 500 |
|
|
|a Date Revised 03.01.2022
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2021 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a mTOR signaling may be a new therapeutic target for IL-6 inhibitor refractory iMCD-NOS
|
| 650 |
|
4 |
|a Case Reports
|
| 650 |
|
4 |
|a Letter
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a Idiopathic multicentric Castleman's disease
|
| 650 |
|
4 |
|a RNA-sequence
|
| 650 |
|
4 |
|a Sirolimus
|
| 650 |
|
4 |
|a Tocilizumab
|
| 650 |
|
4 |
|a mTOR
|
| 650 |
|
7 |
|a Antibodies, Monoclonal, Humanized
|2 NLM
|
| 650 |
|
7 |
|a Immunosuppressive Agents
|2 NLM
|
| 650 |
|
7 |
|a tocilizumab
|2 NLM
|
| 650 |
|
7 |
|a I031V2H011
|2 NLM
|
| 650 |
|
7 |
|a Sirolimus
|2 NLM
|
| 650 |
|
7 |
|a W36ZG6FT64
|2 NLM
|
| 700 |
1 |
|
|a Koga, Tomohiro
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Furukawa, Kaori
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Umeda, Masataka
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yamamoto, Kazuko
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Mori, Ryoichi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kawakami, Atsushi
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 233(2021) vom: 15. Dez., Seite 108887
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:233
|g year:2021
|g day:15
|g month:12
|g pages:108887
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2021.108887
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 233
|j 2021
|b 15
|c 12
|h 108887
|